Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bupivacaine Concentrations for Nerve Block in Inguinal Hernia Repair
NCT05687981Phase 1Unknown
- Sponsor
- Tanta University
- Start
- Jan 2023
- Primary completion
- Dec 2023
- Modality
- Small Molecules
01
Overview
Phase 1, randomised trial of bupivacaine in postoperative pain, sponsored by Tanta University. Primary endpoint: Time to first request for rescue analgesia at 24 hours. Status: unknown.
02
Drugs
bupivacaine
03
Conditions
postoperative pain
Beyond the preview
Go deeper on NCT05687981.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05687981.